Doctor Sergio Barra
Hospital da Luz Arrabida, Vila Nova de Gaia (Portugal)
Follow
Contributor content
Journal
Feasibility of atrial fibrillation burden quantification and its impact on quality-of-life after ablation procedure using continuous monitoring with a smartwatch
12 January 2026
Journal
Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator?
18 July 2017
Journal
Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis
28 June 2017
Journal
Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis
22 December 2016
Journal
Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy
12 November 2015
Journal
Journal
Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations
5 December 2014
Journal
Is atrial fibrillation so common after supraventricular arrhythmia ablation as to require prophylactic treatment?
4 December 2014
Journal
Journal
Early repolarization patterns and the role of additional proarrhythmic triggers
28 December 2012
